chr1-164594188-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002585.4(PBX1):c.265+30877A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.398 in 152,118 control chromosomes in the GnomAD database, including 12,255 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12255 hom., cov: 34)
Consequence
PBX1
NM_002585.4 intron
NM_002585.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.38
Publications
4 publications found
Genes affected
PBX1 (HGNC:8632): (PBX homeobox 1) This gene encodes a nuclear protein that belongs to the PBX homeobox family of transcriptional factors. Studies in mice suggest that this gene may be involved in the regulation of osteogenesis and required for skeletal patterning and programming. A chromosomal translocation, t(1;19) involving this gene and TCF3/E2A gene, is associated with pre-B-cell acute lymphoblastic leukemia. The resulting fusion protein, in which the DNA binding domain of E2A is replaced by the DNA binding domain of this protein, transforms cells by constitutively activating transcription of genes regulated by the PBX protein family. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]
PBX1 Gene-Disease associations (from GenCC):
- congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delayInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Illumina, PanelApp Australia
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.398 AC: 60495AN: 152000Hom.: 12252 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
60495
AN:
152000
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.398 AC: 60518AN: 152118Hom.: 12255 Cov.: 34 AF XY: 0.401 AC XY: 29800AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
60518
AN:
152118
Hom.:
Cov.:
34
AF XY:
AC XY:
29800
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
13003
AN:
41508
American (AMR)
AF:
AC:
6403
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1306
AN:
3470
East Asian (EAS)
AF:
AC:
2651
AN:
5160
South Asian (SAS)
AF:
AC:
2194
AN:
4822
European-Finnish (FIN)
AF:
AC:
4864
AN:
10574
Middle Eastern (MID)
AF:
AC:
119
AN:
292
European-Non Finnish (NFE)
AF:
AC:
28759
AN:
67982
Other (OTH)
AF:
AC:
888
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1901
3801
5702
7602
9503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1734
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.